Stable Istotope Labelled Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade

Reference: PX-TA1396-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Istotope Labelled Risankizumab Biosimilar - Anti-IL23A mAb - Research Grade
SourceCAS 1612838-76-2
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsBI 655066,risankizumab-rzaa
ReferencePX-TA1396-SIL
Related ProductsPX-P5123
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

General information on Anti-IL23A[Homo sapiens] (Risankizumab) Monoclonal Antibody

Risankizumab is a humanized IgG1 monoclonal antibody (mAb) that targets interleukin 23 (IL-23). It has been used for the treatment of moderate-to-severe plaque psoriasis

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below